Rich & Deep in R&D

Halle’s Weinberg Campus Technology Park is a prime location in eastern Germany for international R&D in the fields of life sciences and materials sciences. Since opening its doors in 1993, it has provided a platform for around 250 start-ups.

July 2020

The Weinberg Campus technology park in the state of Saxony-Anhalt is the largest institution of its kind in eastern Germany and brings together more than 100 innovative companies and renowned research institutes focusing on life sciences and materials sciences.

Established in 1993 in the city of Halle, the Weinberg Campus hosts some 5,500 scientists and employees, among them biochemists, biotechnologists, materials scientists, pharmacists, agronomists and nutritionists. The site offers an ideal collaborative environment for applied R&D and production.

A hub for life and materials sciences: the Weinberg Campus has grown from a single building for tech start-ups in 1993 to a science park that employs 5,500 people. © TGZ Halle GmbH/Marco Warmuths

Due to its rich research environment – the campus is home to the Fraunhofer Institute for Microstructure of Materials and Systems (IMWS), the Helmholtz Centre for Environmental Research, the Leibniz Institute of Plant Biochemistry and the Max Planck Institute of Microstructure Physics – it has become a prime location for both domestic and foreign companies, including Heppe Medical Chitosan (HMC+) and RGCC Central Europe, a division of Swiss medical genetics company RGCC Group.

“We are in a particularly advantageous situation thanks to the compact nature of the Weinberg Campus, which means we are near to both the university and the research institutes,” says Katja Richter, managing director of HMC+, which produces a type of biopolymer derived from the shells of crustaceans. “This facilitates productive collaboration and helps us to find new partners.”

Resident firms also include Vivoryon Therapeutics, which develops treatments for Alzheimer’s disease. The company’s investors include a Danish consortium led by Dr. Claus Christiansen, chairman of Denmark’s Nordic Bioscience. Vivoryon is currently partnering with Nordic Bioscience on the development of its PQ912 therapy for Alzheimer’s.

Driving growth and employment


Approximate number of start-ups founded at the Weinberg Campus Technology Park since its establishment in 1993


Approximate number of people currently employed at the Weinberg Campus Technology Park

Source: Weinberg Campus

Dynamic campus with a global focus

Also located on site is Icon Genetics GmbH, a leading player in the plant-based production of biopharmaceuticals and diagnostic reagents. Originally founded in the U.S., Icon is now a subsidiary of Japanese chemical giant Denka. Icon plans to expand operations at the campus to strengthen its position in the biopharma field internationally. The move will bring more highly skilled jobs to the region.

“The researchers and businesses based here have more of a global than a regional focus, so it makes sense for other international businesses to locate here or to seek out potential partners,” says the managing director of the Weinberg Campus, Dr. Ulf-Marten Schmieder. “Our vision is that we will have joined the top flight of international tech parks in 10 years’ time.”

replies (0)

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2018 Germany Trade & Invest